JP2025504374A5 - - Google Patents
Info
- Publication number
- JP2025504374A5 JP2025504374A5 JP2024540866A JP2024540866A JP2025504374A5 JP 2025504374 A5 JP2025504374 A5 JP 2025504374A5 JP 2024540866 A JP2024540866 A JP 2024540866A JP 2024540866 A JP2024540866 A JP 2024540866A JP 2025504374 A5 JP2025504374 A5 JP 2025504374A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- disease
- independently
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263297444P | 2022-01-07 | 2022-01-07 | |
| US63/297,444 | 2022-01-07 | ||
| PCT/US2023/010314 WO2023133271A1 (en) | 2022-01-07 | 2023-01-06 | Bicyclic phthalazin-1(2h)-one derivatives and related uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504374A JP2025504374A (ja) | 2025-02-12 |
| JP2025504374A5 true JP2025504374A5 (enExample) | 2025-12-18 |
Family
ID=85239129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540866A Pending JP2025504374A (ja) | 2022-01-07 | 2023-01-06 | 二環式フタラジン－１（２ｈ）－オン誘導体および関連する使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250066369A1 (enExample) |
| EP (1) | EP4460505A1 (enExample) |
| JP (1) | JP2025504374A (enExample) |
| KR (1) | KR20240145992A (enExample) |
| CN (1) | CN118922421A (enExample) |
| AU (1) | AU2023205048A1 (enExample) |
| CA (1) | CA3247232A1 (enExample) |
| IL (1) | IL314035A (enExample) |
| MX (1) | MX2024008477A (enExample) |
| WO (1) | WO2023133271A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| RU2364597C1 (ru) * | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ |
| CA3189887A1 (en) * | 2020-09-24 | 2022-03-31 | Daniel Oehlrich | New compounds |
-
2023
- 2023-01-06 IL IL314035A patent/IL314035A/en unknown
- 2023-01-06 EP EP23705320.2A patent/EP4460505A1/en active Pending
- 2023-01-06 JP JP2024540866A patent/JP2025504374A/ja active Pending
- 2023-01-06 US US18/726,919 patent/US20250066369A1/en active Pending
- 2023-01-06 AU AU2023205048A patent/AU2023205048A1/en active Pending
- 2023-01-06 KR KR1020247026276A patent/KR20240145992A/ko active Pending
- 2023-01-06 CA CA3247232A patent/CA3247232A1/en active Pending
- 2023-01-06 MX MX2024008477A patent/MX2024008477A/es unknown
- 2023-01-06 WO PCT/US2023/010314 patent/WO2023133271A1/en not_active Ceased
- 2023-01-06 CN CN202380025701.8A patent/CN118922421A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022536160A5 (enExample) | ||
| JP2023540733A5 (enExample) | ||
| KR20230057411A (ko) | 바이러스 감염 치료를 위한 화합물 및 방법 | |
| JP2021534124A5 (enExample) | ||
| JP2021523159A5 (enExample) | ||
| HRP20250964T1 (hr) | Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma | |
| JP2023540344A5 (enExample) | ||
| JP2020529405A5 (enExample) | ||
| JP2019520417A5 (enExample) | ||
| JP2016525130A5 (enExample) | ||
| JP2019519598A5 (enExample) | ||
| JP2022535956A5 (enExample) | ||
| JP2011523412A5 (enExample) | ||
| JP2018531289A5 (enExample) | ||
| JP2016500661A5 (enExample) | ||
| JP2013522232A5 (enExample) | ||
| JP2020518571A5 (enExample) | ||
| US20230348437A1 (en) | Compounds, compositions and methods | |
| JP2022535955A5 (enExample) | ||
| JP2019533682A (ja) | 抗ｃｄ１９抗体とｂｃｌ−２阻害剤との組み合わせおよびその使用 | |
| JP2019513703A (ja) | ＮｏｔｃｈシグナリングのエンハンサーならびにＮｏｔｃｈのアップレギュレーションにより治療可能ながんおよび悪性腫瘍の治療におけるその使用 | |
| HRP20240896T1 (hr) | Derivati sulfoniluree i njihova upotreba | |
| JP2022522890A5 (enExample) | ||
| CN111936136A (zh) | 新咪唑并嘧啶化合物及其用途 | |
| CN110049768B (zh) | 酚噻嗪衍生物及其使用方法 |